Veteran Caregiver Reeducation, Reemployment, and Retirement Act

The Veteran Caregiver Reeducation, Reemployment, and Retirement Act (HR2148) was introduced on March 14, 2025, and aims to expand medical and employment benefits for family caregivers of veterans. The bill was referred to the Committees on Veterans' Affairs and Ways and Means. On February 12, 2026, the House Committee on Veterans' Affairs ordered the bill to be reported in the nature of a substitute (amended) by voice vote, indicating bipartisan support and progress. The bill is currently awaiting floor action in the House of Representatives. This bill does not specify an explicit funding amount but creates new revenue streams by extending medical coverage for primary family caregivers for 180 days post-designation removal (unless dismissed for fraud/abuse or entitled to Medicare) and mandating the VA to provide bereavement counseling, support, and retirement planning services. It also includes employment assistance such as reimbursement for certifications/relicensure and access to VA training modules. These provisions will increase demand for healthcare services and insurance coverage, with the costs borne by the Department of Veterans Affairs, which will require subsequent appropriations. Structural winners include healthcare providers and insurance companies. Companies like CVS Health Corporation ($CVS), UnitedHealth Group Incorporated ($UNH), Humana Inc. ($HUM), Elevance Health, Inc. ($ELV), and The Cigna Group ($CI) are positioned to benefit from the expansion of medical coverage and increased utilization of healthcare services by veteran caregivers. The bill's focus on reeducation and reemployment may also indirectly benefit educational and vocational training providers, though no specific tickers are identified in the provided data. Recent market data shows that over the past 7 days, all listed healthcare insurers have seen positive movement: Humana Inc. ($HUM) is up +10.03% at $182.65, UnitedHealth Group Incorporated ($UNH) is up +7.48% at $281.36, The Cigna Group ($CI) is up +6.82% at $275.69, Elevance Health, Inc. ($ELV) is up +6.26% at $302.61, and CVS Health Corporation ($CVS) is up +4.48% at $73.28. With the bill reported out of committee, the next legislative step is a vote on the House floor. A companion bill, S879, has also been ordered to be reported favorably in the Senate, which increases the probability of eventual passage. The bipartisan sponsorship (Rep. Morelle, D-NY, and Rep. Ciscomani, R-AZ) and the committee's voice vote indicate broad support, suggesting a reasonable path forward for the legislation.